PSOGI World News - December 2024 Newsletter
- PFCCAP Admin
- Jan 6
- 2 min read
A quarterly newsletter with the latest news, views and announcements from Peritoneal Surface Oncology Group International (PSOGI)
Led by pioneering surgical oncologist Dr. Paul Sugarbaker, PSOGI is a collaboration of experts from around the world on the treatment of peritoneal cancer and is dedicated to improving treatment and survival of patients with peritoneal metastases. While PSOGI World News is a quarterly publication primarily intended for healthcare professionals, this issue offers valuable insights for patients and caregivers navigating these complex cancers.
We are proud to share their quarterly newsletter here.
The December 2024 issue includes a classification of pseudomyxoma peritonei (PMP) by Dr. Paul H. Sugarbaker. His detailed explanation of how mutations and perforations lead to PMP development helps us understand the disease’s progression and the importance of early intervention. This knowledge empowers patients to engage in informed conversations with their medical teams.
A feature on the Peritoneal Malignancy Institute in Basingstoke, UK highlights its leadership in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Caregivers and patients can learn about innovative treatment approaches, successful patient outcomes, and the significance of specialized cancer centers.
The newsletter also introduces Radspherin®, a novel alpha-radiopharmaceutical for post-surgery treatment, offering hope for those concerned about microscopic residual disease. Patients seeking alternative therapies may find this promising.
A tribute to Dr. John Stricklin Spratt, Jr. celebrates a pioneer in peritoneal cancer research. Understanding the history of medical advancements can offer reassurance and build confidence in modern treatments.
Additionally, Dr. Shigeki Kusamura discusses the bidirectional approach for treating gastric cancer metastases, combining PIPAC (pressurized intraperitoneal aerosol chemotherapy) and systemic chemotherapy. Patients exploring their treatment options can benefit from understanding these emerging strategies.
Overall, this issue of PSOGI World News serves as a reliable source of information for patients and caregivers, providing clarity on treatment options, emerging therapies, and the importance of specialized care in managing peritoneal surface malignancies.
Read the full December 2024 issue of PSOGI World News here:
